Literature DB >> 9249691

Antibodies to multiple tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in white-footed mice.

L A Magnarelli1, J F Anderson, K C Stafford, J S Dumler.   

Abstract

Serum samples from Peromyscus leucopus (white-footed mouse), collected in Connecticut (USA) in 1983, 1985, and during 1990 to 1993, were analyzed by an enzyme-linked immunosorbent assay (ELISA) or indirect fluorescent antibody (IFA) staining methods for antibodies to Borrelia burgdorferi (strain 2591), Babesia microti, Ehrlichia chaffeensis (Arkansas strain), and Ehrlichia equi (MRK strain). Of the 294 serum samples tested, 160 (54%) contained immunoglobulins to one or more of these pathogens. There were antibodies to two or more etiologic agents in 77 (48%) of the seropositive mice. Although it was uncommon to detect coexisting antibodies to all four pathogens (n = 5 positive mice), E. chaffeensis-reactive antibodies or immunoglobulins to E. equi were present along with those produced to B. burgdorferi and B. microti in 24 other mice. These rodents carry antibodies to several tick-borne pathogens at numerous sites in Connecticut and may play a role in the epizootiology of ehrlichiosis as well as babesiosis and Lyme borreliosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249691     DOI: 10.7589/0090-3558-33.3.466

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  24 in total

1.  Molecular characterization of Anaplasma phagocytophilum and Borrelia burgdorferi in Ixodes scapularis ticks from Pennsylvania.

Authors:  Joshua W Courtney; Richard L Dryden; Jill Montgomery; Bradley S Schneider; Gary Smith; Robert F Massung
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  Detection of Ehrlichia chaffeensis DNA in Amblyomma americanum ticks in Connecticut and Rhode Island.

Authors:  J W Ijdo; C Wu; L A Magnarelli; K C Stafford; J F Anderson; E Fikrig
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

Review 3.  Coinfections acquired from ixodes ticks.

Authors:  Stephen J Swanson; David Neitzel; Kurt D Reed; Edward A Belongia
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

4.  Infection with agents of human granulocytic ehrlichiosis, lyme disease, and babesiosis in wild white-footed mice (Peromyscus leucopus) in Connecticut.

Authors:  K C Stafford; R F Massung; L A Magnarelli; J W Ijdo; J F Anderson
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

5.  Isolation of the etiologic agent of human granulocytic ehrlichiosis from the white-footed mouse (Peromyscus leucopus).

Authors:  M D Ravyn; C B Kodner; S E Carter; J L Jarnefeld; R C Johnson
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  Human exposure to a granulocytic Ehrlichia and other tick-borne agents in Connecticut.

Authors:  L A Magnarelli; J W Ijdo; J F Anderson; S J Padula; R A Flavell; E Fikrig
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

7.  Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates.

Authors:  M D Ravyn; J L Goodman; C B Kodner; D K Westad; L A Coleman; S M Engstrom; C M Nelson; R C Johnson
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  Multiplex real-time PCR for detection of anaplasma phagocytophilum and Borrelia burgdorferi.

Authors:  Joshua W Courtney; Leah M Kostelnik; Nordin S Zeidner; Robert F Massung
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  Disparity in the natural cycles of Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis.

Authors:  M L Levin; F des Vignes; D Fish
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

10.  Naturally occurring Ehrlichia chaffeensis infection in coyotes from Oklahoma.

Authors:  A A Kocan; G C Levesque; L C Whitworth; G L Murphy; S A Ewing; R W Barker
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.